We are live on ! Find out more
INGN icon

Inogen

150 hedge funds and large institutions have $280M invested in Inogen in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 37 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

92% more call options, than puts

Call options by funds: $177K | Put options by funds: $92K

68% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 37

12% more funds holding

Funds holding: 134150 (+16)

7.14% more ownership

Funds ownership: 90.45%97.58% (+7.1%)

31% less capital invested

Capital invested by funds: $409M → $280M (-$128M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
150
Holders Change
+16
Holders Change %
+11.94%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
62
Reduced
37
Closed
11
Calls
$177K
Puts
$92K
Net Calls
+$85K
Net Calls Change
+$134K

INGN Hedge Fund Activity: Q1 2023 in Review

150 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q1 2023, worth a combined $280M — down 31% from $409M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INGN positions and 11 closed out — a net gain of 18 holders — while 62 added to existing stakes and 37 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $12.8M. The largest seller was BAMCO Inc, exiting entirely with an estimated $19.2M sold.

  • 150 institutional investors held Inogen (INGN) as of Q1 2023, up from 134 in Q4 2022.
  • Funds reported $280M of Inogen stock for Q1 2023, down 31% quarter-over-quarter.
  • 29 funds opened new Inogen positions in Q1 2023 and 11 closed out, a net change of +18 holders.
  • The largest Inogen buyer in Q1 2023 was Camber Capital Management, an estimated $12.8M added.
  • The largest Inogen seller in Q1 2023 was BAMCO Inc, an estimated $19.2M sold.

Based on aggregated 13F filings for Q1 2023.